Skip to main content
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
  • IFU
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • +32 15 632 600
  • Subscribe to news
  • Global
  • United States

NOW AVAILABLE: Idylla POLE-POLD1 Mutation Assay (RUO) - Read more

NEW DATA: Early CAR-T vector load assessment with Idylla -  Read more

NEW MDACC STUDY: The potential of Idylla to deliver  fast results directly in the cytopathology lab - Read more

NEW STUDY: Idylla EGFR Mutation Test shortens time to patient management decisions for NSCLC patients - Read more

Biocartis

Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact

Our Mission & Vision

Biocartis’ vision is to enable personalized medicine for patients around the world through universal access to molecular testing. Our mission is to make molecular testing actionable, easy, fast and suitable for any lab.

267633s_1bioc-world_mission_vision.jpg
Meet Idylla

Meet Idylla

IdyllaTM - A revolutionary, fully automated system that makes molecular testing easy, fast and suitable for any lab.

Learn more
header_2 women_no biocartis

Oncology

Molecular biomarker results in only 3 hours for fast treatment decisions!

THINK IDYLLA™

Learn more
Research Biocartis

Oncology Research

Biocartis encourages the research into new and emerging uses of different biomarkers.

Learn more
Partners Biocartis

Partnering

Biocartis believes in the power of collaboration and has partnership programs with pharmaceutical and diagnostic or biomarker companies

Learn more

Disease area oncology

Lung Cancer

Read more

Colorectal Cancer

Read more

Melanoma

Read more
  • Meet Idylla
  • Oncology
  • Oncology Research
  • Partnering
  • Press & Events
  • About Us

Biocartis NV

Generaal De Wittelaan 11B

2800 Mechelen, Belgium

Phone: +32 15 632 600

[email protected]

 

Biocartis US

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2025 Biocartis Created by O2 Agency